Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2014
06/25/2014CN103889969A 新方法 New Method
06/25/2014CN103880862A 丙型肝炎病毒复制的抑制剂 Inhibitors of hepatitis C virus replication
06/25/2014CN103880844A 一种喹啉酮类新化合物及其制备方法与用途 One kind of new quinolone compound and its preparation method and uses
06/25/2014CN103880843A 6-溴咪唑并[1,2-a]吡啶-3-甲腈的合成方法 Synthesis of 6-bromo-imidazo [1,2-a] pyridine-3-carbonitrile
06/25/2014CN103880842A 具HDAC抑制活性的β-咔啉类衍生物及制备方法和用途 With HDAC inhibitory activity of β- carboline derivatives and the preparation and use
06/25/2014CN103880841A 含有β-咔啉-3-酰亚肼基的HDAC抑制剂及其制备方法和用途 HDAC inhibitors and their preparation and use containing β- carboline-3-acid hydrazonopropionate of
06/25/2014CN103880840A 一种以伊喹酮为母体的表面活性物质及其制备技术 Methaqualone in Iraq for a surface-active substances and preparation techniques mother
06/25/2014CN103880839A 13a-(S)去氧娃儿藤宁衍生物、其药物组合物与用途 13a- (S) tylophora Ning-deoxy derivatives, pharmaceutical compositions and uses
06/25/2014CN103880731A 新有机电致发光化合物和使用该化合物的有机电致发光设备 The new organic electroluminescent compounds and the use of the compound organic electroluminescent devices
06/25/2014CN103880707A Stat3小分子抑制剂及其应用 Stat3 small molecule inhibitors and their applications
06/25/2014CN103045230B 一种PET型Fe<sup>3+</sup>荧光探针及其制备方法和应用 One kind of PET-based Fe <sup> 3 + </ sup> fluorescent probe and its preparation method and application
06/25/2014CN102617568B 一种稳定的盐酸莫西沙星化合物、其制备方法 Moxifloxacin hydrochloride in a stable compound, its preparation method
06/25/2014CN102574852B Akt抑制剂 Akt inhibitors
06/25/2014CN102333777B 含氮的稠合杂环化合物及其作为β淀粉样蛋白生成抑制剂的用途 Nitrogen-containing fused heterocyclic compounds and their use as inhibitors of β-amyloid protein production purposes
06/25/2014CN102216297B (二氢)吡咯并[2，1-a]异喹啉类 (Dihydro) pyrrolo [2,1-a] isoquinoline
06/25/2014CN102056927B 作为激酶抑制剂的稠合含氮杂环及其组合物 As kinase inhibitors condensed nitrogen-containing heterocyclic, and combinations thereof
06/25/2014CN102046240B 新的p2x7r拮抗剂及其应用 New p2x7r antagonist and its applications
06/25/2014CN101759645B p38抑制剂及它们的使用方法 p38 inhibitors and methods for their use
06/24/2014US8759367 Compounds and methods for the prevention and treatment of cancer
06/24/2014US8759362 Bicycloheteroaryl compounds and their use as TRPV1 ligands
06/24/2014US8759357 Inhibitors of fatty acid binding protein (FABP)
06/24/2014US8759346 Organic compounds
06/24/2014US8759345 Benzoimidazoles as prolyl hydroxylase inhibitors
06/24/2014US8759344 Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof
06/24/2014US8759341 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
06/24/2014US8759332 Hepatitis C virus inhibitors
06/19/2014WO2014093383A1 Substituted 1h-pyrrolo [2,3-b] pyridine and 1h-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (sik2) inhibitors
06/19/2014WO2014092061A1 Hydantoin derivative
06/19/2014WO2014092006A1 Novel octahydropyridoquinazoline derivative, pharmaceutical composition containing same, and uses for said derivative and composition
06/19/2014WO2014091446A1 Pyrimido [4,5-b]quinoline-4,5 (3h,10h)-diones as nonsense mutation suppressors
06/19/2014WO2014091298A2 Nitrogen containing morphinan derivatives and the use thereof
06/19/2014WO2014091297A1 Spirocyclic morphinans and their use
06/19/2014WO2014091295A1 Pyridonemorphinan analogs and biological activity on opioid receptors
06/19/2014WO2014091268A1 NEW BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS
06/19/2014WO2014089904A1 Triazinone compounds
06/19/2014WO2014063054A8 Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
06/19/2014US20140171639 Trpm8 antagonists and their use in treatments
06/19/2014US20140171462 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 h-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
06/19/2014US20140171461 Nitrogen Containing Morphinan Derivatives and the Use Thereof
06/19/2014US20140171451 Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones
06/19/2014US20140171439 Inhibitors Of Histone Deacetylase
06/19/2014US20140171434 Substituted imidazopyridines and imidazopyridazines and the use thereof
06/19/2014US20140171432 Histone demethylase inhibitors
06/19/2014US20140171429 Bicyclic inhibitors of alk
06/19/2014US20140171425 Quinazoline-2,4-dione derivatives
06/19/2014US20140171422 Pyrimidodiazepinone compound
06/19/2014US20140171421 Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
06/19/2014US20140171420 Diazole lactams
06/19/2014US20140171418 Antibacterial homopiperidinyl substituted 3,4 dihydro 1H[1,8]naphthyridinones
06/19/2014US20140171417 Tricyclic compounds
06/19/2014US20140171409 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
06/19/2014US20140171407 1,7-diazacarbazoles and methods of use
06/19/2014US20140171406 Trpm8 antagonists and their use in treatments
06/19/2014US20140171405 Fused Pyrazoles as FGFR Inhibitors
06/19/2014US20140171336 Methods and Kits Using Extended Rhodamine Dyes
06/19/2014US20140170110 Pyridin-2(1h)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
06/18/2014EP2743266A2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon
06/18/2014EP2742047A1 Antibacterial piperidinyl substituted 3,4-dihydro-1h-[1,8]naphthyridinones
06/18/2014EP2742046A1 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE
06/18/2014EP2742045A1 Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones
06/18/2014EP2742044A1 Antibacterial homopiperidinyl substituted 3,4 dihydro 1h [1,8]naphthyridinones
06/18/2014EP2742043A1 Pyrido-pyrimidine derivatives
06/18/2014EP2742040A1 Indazole compounds, compositions and methods of use
06/18/2014CN103874701A Pyridine compounds and uses thereof
06/18/2014CN103874700A Pyrazolo[3,4-c]pyridine compounds and methods of use
06/18/2014CN103874699A Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors
06/18/2014CN103874698A Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones
06/18/2014CN103874697A Dibenzooxepin derivative
06/18/2014CN103874688A Herbicidal pyridazinone derivatives
06/18/2014CN103874686A Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)
06/18/2014CN103865526A Main material based on phenanthrene and imidazole derivative and electroluminescent device
06/18/2014CN103864790A Process for preparing cytisine from thermopsis lanceolata glasses and seeds
06/18/2014CN103864789A Novel compounds for organic electronic material and organic electronic device using the same
06/18/2014CN103864788A N<5>,N<10>-methylene-8-deazatetrafolate, and synthetic method and application thereof
06/18/2014CN103864787A Green synthetic method of beta-carboline compound
06/18/2014CN103864786A Method for synthesizing 6-fluoroimidazo-[1,2-a]-pyridine-3-formic acid
06/18/2014CN103864785A Thiazoline derivatives with aza-indole framework as well as preparation method and application thereof
06/18/2014CN103864784A Novel azaindole-2-ketone FGFR1 (Fibroblast Growth Factor Receptor1) inhibitor and anti-tumor activity thereof
06/18/2014CN103864783A Compounds for the Treatment of Hepatitis C
06/18/2014CN103864782A Synthetic method and application of HIV-1 retrovirus inhibitor N<5>,N<10>-dimethyl-8-deazatetrafolate
06/18/2014CN103864781A Novel 1,9-disubstituted tetrahydrocarboline derivative preparation, and application of 1,9-disubstituted tetrahydrocarboline derivatives in anti-tumor drugs
06/18/2014CN103864780A Preparation of new drug 1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid methyl ester derivatives and application in antitumor drugs
06/18/2014CN103864779A Preparation of 1-(phenyl)-2,3,4,9-tetrahydro-1H-pyridino[3,4-b]indole derivatives and application of derivatives in antitumor drugs
06/18/2014CN103864696A Synthetic and technological method of 1,2,3,4-tetrahydrophthalazine compound
06/18/2014CN102307870B Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease
06/18/2014CN102209711B Compounds for the treatment of hepatitis C
06/18/2014CN102093751B Pigment particle dispersion body, photo-curing composition and color filter using dispersion
06/18/2014CN101945869B Pyrido[2,3-b]pyrazine-8-substituted compounds and their use
06/18/2014CN101890018B Tyrosine protein kinase inhibitor and preparation method thereof
06/18/2014CN101448780B 2,5-di(methoxyanilino)terephthalic acid polymorphs and quinacridones realized therefrom
06/17/2014US8754214 Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
06/17/2014US8754107 Aminopyrrolidines as chemokine receptor antagonists
06/17/2014US8754102 Nitrogen containing compounds and their use
06/17/2014US8754100 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
06/17/2014US8754097 Piperidine and piperazine derivatives
06/17/2014US8754096 Piperidinone carboxamide azaindane CGRP receptor antagonists
06/17/2014US8754078 Compositions and methods for treatment of cancer
06/17/2014CA2725014C Inhibitors of pi3 kinase
06/17/2014CA2630273C Heterocyclylalkyl derivatives as inhibitors of histone deacetylase
06/17/2014CA2507607C Heterocyclic compounds, their preparation and their use as medication, specifically as anti-bacterials and inhibitors of beta-lactamases
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 646